Compare DHX & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DHX | ZTEK |
|---|---|---|
| Founded | 1991 | 2008 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Business Services | Major Chemicals |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 81.1M | 89.3M |
| IPO Year | 2007 | N/A |
| Metric | DHX | ZTEK |
|---|---|---|
| Price | $1.54 | $0.70 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $4.75 | N/A |
| AVG Volume (30 Days) | ★ 272.7K | 46.1K |
| Earning Date | 02-04-2026 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $131,236,000.00 | $657,134.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 2225.73 |
| 52 Week Low | $1.21 | $0.62 |
| 52 Week High | $3.34 | $1.84 |
| Indicator | DHX | ZTEK |
|---|---|---|
| Relative Strength Index (RSI) | 40.50 | 47.27 |
| Support Level | $1.53 | $0.64 |
| Resistance Level | $1.78 | $0.76 |
| Average True Range (ATR) | 0.10 | 0.04 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 44.12 | 65.81 |
DHI Group Inc is a provider of artificial intelligence-powered software products, online tools and services to deliver career marketplaces to candidates and employers globally. DHI's brands includes Dice and Clearance Jobs enable recruiters and hiring managers to efficiently search, match and connect with skilled technologists in specialized fields, particularly technology and those with active government security clearances. The company derive the majority of revenue came from the sale of recruitment packages, which allow customers to promote jobs on websites and source candidates through their resume databases. Recruitment packages are typically provided through contractual arrangements with annual, quarterly or monthly payment terms.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.